ArticleThe Laryngoscope2026
Disease-Specific Improvements Predict Long-Term Global Quality of Life After Functional Rhinoplasty.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFunctional rhinoplasty can improve disease-specific quality of life (QoL) domains. However, less is understood about its association with global health-related QoL outcomes. The goal of this study is to evaluate the relationship between disease-specific and long-term global QoL outcomes following functional rhinoplasty.
methodsProspective cohort study at a tertiary medical center of patients undergoing functional rhinoplasty for nasal airway obstruction.
resultsFifty patients (58% female, 42% male), with a mean age of 38.5 (StD 14.7), were surveyed. Baseline and long term (> 6 months) follow up Euroqol-5D (EQ-5D) and Standard Cosmesis and Health Nasal Outcomes Survey (SCHNOS) questionnaires were collected. Mean baseline SCHNOS-Obstructive (SCHNOS-O) score improved from 77.5 (95% CI: 71.5-83.5) to 22.7 (95% CI: 14.4-31.1) at follow up. Mean SCHNOS-Cosmesis (SCHNOS-C) score improved from 44.9 (95% CI: 33.9-56.0) to 13.9 (95% CI: 8.9-21.1). A higher SCHNOS-O is a significant predictor for expressing pain/discomfort at follow up (p = 0.011). A higher SCHNOS-C is a significant predictor for expressing anxiety/depression at follow up (p = 0.019). There is no relationship between SCHNOS-O/SCHNOS-C and mobility, self-care, or activity. A greater improvement in SCHNOS-O is associated with less anxiety/depression (p = 0.03) and pain/discomfort (p = 0.02) at follow up. However, a greater improvement in SCHNOS-C is not significantly associated with anxiety/depression (p = 0.678) or pain/discomfort (p = 0.558) at follow up. Patients who expressed anxiety/depression at baseline are more likely to express anxiety/depression at follow up.
conclusionPatients with long-term improvements in nasal obstruction, but not cosmesis, are less likely to report long-term anxiety/depression and pain/discomfort following functional rhinoplasty. LEVEL OF EVIDENCE: 4:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.